![](https://news.europawire.eu/wp-content/uploads/2023/03/esc.jpg)
European Parliament Approves Landmark Pharmaceutical Legislation Reform, Calls for Further Enhancements
(IN BRIEF) The European Parliament has achieved a significant milestone by approving the first reading of extensive reforms to EU pharmaceutical legislation aimed at fostering innovation and ensuring equitable access to medicines. While commending the progress, the European Society of Cardiology (ESC) emphasizes the need for addressing remaining shortcomings and ensuring alignment with patients’ needs, particularly in therapeutic areas such as cardiovascular disease (CVD). The ESC advocates for measures to identify and address innovation gaps, bolster regulatory systems, and extend support to chronic conditions like CVD through initiatives such as PRIME and enhanced collaboration between regulatory authorities and healthcare professionals. The ESC’s recommendations seek to promote a healthcare landscape that prioritizes patient needs and fosters innovation to meet unmet medical requirements effectively.
(PRESS RELEASE) SOPHIA ANTIPOLIS, 27-May-2024 — /EuropaWire/ — Next week about 400 million European citizens will be called to elect the 720 members of the European Parliament that will represent them in the next legislative term. Among their responsibilities, the new Members of the European Parliament (MEPs) will be negotiating the reform of the EU pharmaceutical legislation with the Council.
The file is the most extensive reform in the sector in more than 20 years and aims to promote innovation while ensuring timely and equitable access to medicines.
The European Society of Cardiology (ESC) takes this opportunity to congratulate the Parliament on reaching a first reading approval of the file within the current legislative term. While welcoming this step forward and the introduction of some positive additions, we urge the Council and the newly elected MEPs to address some remaining shortcomings.
Professor Piotr Szymański, Chair of ESC Regulatory Affairs Committee, said: “The primary objective of the reform is to guarantee timely and fair access to medications for patients across the EU and to foster the retention of research and innovation activities within Europe. A unified approach at the EU level should offer increased opportunities for incentivising innovation and coordinating efforts to develop and deliver medicinal products addressing unmet medical needs, especially in the areas where innovation remains significantly out of proportion to the disease burden”.
The ESC commends the progress made in strengthening the consultation of healthcare professionals in the regulatory process, including for the drafting of scientific guidelines – such as on unmet medical needs – and for the adoption of measures to prevent and manage shortages.
Health professionals’ expertise and direct contact with patients are essential to enhance the relevance and effectiveness of regulatory measures. In particular, consultation of health professionals representing medical societies is crucial to gather collective views and foster alignment with clinical practice guidelines. The guidelines play an important role in shaping clinical practice of European physicians, by providing evidence-based recommendations that improve quality of healthcare delivery.
Other improvements introduced by the Parliament that the ESC calls the Council to uphold, concern:
- Repurposing of authorised medicines, allowing not-for-profit entities to present evidence to regulators for a new therapeutic indication even if not addressing an unmet medical need. Repurposing can effectively broaden access and provide significant benefits to patients and should have a wide scope.
- Prevention and management of shortages, including the requirement for National Competent Authorities to recommend to health professionals alternative medicines to use in the case of shortages.
- Transparency on financial support received for research and development, which was extended to indirect public funding and to licenses or acquisitions from other entities. Enhanced transparency on R&D costs and exchange of expertise on pricing, reimbursement and procurement policies can contribute to the sustainability of health systems.
Nevertheless, the ESC is concerned that while the reform provides targeted measures and incentives for a number of major public health needs, it fails to address the emerging misalignment between burden of disease and innovation in some therapeutic areas, including cardiovascular disease (CVD). Although CVD remains the leading cause of death and morbidity in Europe, research and development is out of proportion to its burden and woefully lagging with respect to other therapeutic areas. Out of 80 new active substances authorized between 2022 and 2023, only one was in CVD[1] and only 4% of the trials started between 2017 and 2022 were for CVD[2]. This misalignment also constitutes an unmet medical need, which should be recognised and addressed to provide European patients with the treatments they need.
Building on the Commission’s proposal and on the negotiations held in the Parliament, the ESC recommends the following provisions which would help achieve this objective:
- Identify and address innovation gaps: Regulators and policymakers should proactively identify therapeutic areas where innovation is stagnating despite a remaining high disease burden, representing unmet medical needs. Such information should be used to investigate causes and possible solutions, consulting relevant health professional associations.
An agile and responsive regulatory system should encourage R&D to stay in Europe. In parallel, reinforcing public research is also key to filling existing gaps. - HERA’s & ECDC’s mandate: Considering the new role and responsibilities proposed by the Parliament for the Health Emergency Preparedness and Response Authority (HERA) under the European Centre for Disease Prevention and Control (ECDC), such innovation gaps should also be considered, especially when it comes to the definition of a long-term European R&D portfolio and collaboration with third-party research centers, not-for profit entities and academia. As requested by MEPs in the framework of negotiations on Regulation (EU) 2022/2370[3], the ECDC’s mandate should be extended to encompass major non-communicable diseases, gathering crucial epidemiological data for research and policymaking.
- Unmet Medical Needs: Unmet needs also exist in chronic, progressive, and highly prevalent conditions, which pose a significant burden to individual and public health.
The definition provided by the directive should take this into consideration and also better reflect patients’ and societal needs. - PRIME: Out of 384 PRIME requests received by EMA between 1 January 2016 and 30 June 2021, only 20 were for CVD and just 2 were granted eligibility to the scheme[4]. Extending the scope of PRIME to encompass chronic conditions associated with high mortality and morbidity would significantly benefit European patients.
References
[1] Elaboration on EMA Human Medicines Highlights 2022 and 2023: https://www.ema.europa.eu/system/files/documents/report/human_medicines_highlights_2022_update_3_may_en.pdf; https://www.ema.europa.eu/en/documents/other/human-medicines-highlights-2023_en.pdf
[2] EFPIA Pipeline Innovation Review, August 2022: https://www.efpia.eu/media/676661/iqvia_efpia-pipeline-review_final-report_public-final.pdf
[3] https://www.europarl.europa.eu/news/en/press-room/20210625IPR07001/enhancing-eu-s-disease-prevention-and-control-capacity
[4] Piotr Szymański, Faiez Zannad, Thomas F Lüscher, Urgent need to define unmet medical needs in cardiovascular diseases, European Heart Journal, Volume 45, Issue 16, 21 April 2024, Pages 1384–1385, https://doi.org/10.1093/eurheartj/ehae041
About the European Society of Cardiology
The ESC brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people to live longer, healthier lives.
Media Contact:
ESC Press Office
Tel: +33 6 61 40 18 84
Email: press@escardio.org
SOURCE: European Society of Cardiology (ESC)
MORE ON EUROPEAN SOCIETY OF CARDIOLOGY, ESC, ETC.:
- Astor Asset Management 3 Ltd: Salinas Pliego Incumple Préstamo de $110 Millones USD y Viola Regulaciones Mexicanas
- Astor Asset Management 3 Ltd: Salinas Pliego Verstößt gegen Darlehensvertrag über 110 Mio. USD und Mexikanische Wertpapiergesetze
- ChargeEuropa zamyka rundę finansowania, której przewodził fundusz Shift4Good tym samym dokonując historycznej francuskiej inwestycji w polski sektor elektromobilności
- Strengthening EU Protections: Robert Szustkowski calls for safeguarding EU citizens’ rights to dignity
- Digi Communications NV announces the release of H1 2024 Financial Results
- Digi Communications N.V. announces that conditional stock options were granted to a director of the Company’s Romanian Subsidiary
- Digi Communications N.V. announces Investors Call for the presentation of the H1 2024 Financial Results
- Digi Communications N.V. announces the conclusion of a share purchase agreement by its subsidiary in Portugal
- Digi Communications N.V. Announces Rating Assigned by Fitch Ratings to Digi Communications N.V.
- Digi Communications N.V. announces significant agreements concluded by the Company’s subsidiaries in Spain
- SGW Global Appoints Telcomdis as the Official European Distributor for Motorola Nursery and Motorola Sound Products
- Digi Communications N.V. announces the availability of the instruction regarding the payment of share dividend for the 2023 financial year
- Digi Communications N.V. announces the exercise of conditional share options by the executive directors of the Company, for the year 2023, as approved by the Company’s Ordinary General Shareholders’ Meetings from 18th May 2021 and 28th December 2022
- Digi Communications N.V. announces the granting of conditional stock options to Executive Directors of the Company based on the general shareholders’ meeting approval from 25 June 2024
- Digi Communications N.V. announces the OGMS resolutions and the availability of the approved 2023 Annual Report
- Czech Composer Tatiana Mikova Presents Her String Quartet ‘In Modo Lidico’ at Carnegie Hall
- SWIFTT: A Copernicus-based forest management tool to map, mitigate, and prevent the main threats to EU forests
- WickedBet Unveils Exciting Euro 2024 Promotion with Boosted Odds
- Museum of Unrest: a new space for activism, art and design
- Digi Communications N.V. announces the conclusion of a Senior Facility Agreement by companies within Digi Group
- Digi Communications N.V. announces the agreements concluded by Digi Romania (formerly named RCS & RDS S.A.), the Romanian subsidiary of the Company
- Green Light for Henri Hotel, Restaurants and Shops in the “Alter Fischereihafen” (Old Fishing Port) in Cuxhaven, opening Summer 2026
- Digi Communications N.V. reports consolidated revenues and other income of EUR 447 million, adjusted EBITDA (excluding IFRS 16) of EUR 140 million for Q1 2024
- Digi Communications announces the conclusion of Facilities Agreements by companies from Digi Group
- Digi Communications N.V. Announces the convocation of the Company’s general shareholders meeting for 25 June 2024 for the approval of, among others, the 2023 Annual Report
- Digi Communications NV announces Investors Call for the presentation of the Q1 2024 Financial Results
- Digi Communications intends to propose to shareholders the distribution of dividends for the fiscal year 2023 at the upcoming General Meeting of Shareholders, which shall take place in June 2024
- Digi Communications N.V. announces the availability of the Romanian version of the 2023 Annual Report
- Digi Communications N.V. announces the availability of the 2023 Annual Report
- International Airlines Group adopts Airline Economics by Skailark ↗️
- BevZero Spain Enhances Sustainability Efforts with Installation of Solar Panels at Production Facility
- Digi Communications N.V. announces share transaction made by an Executive Director of the Company with class B shares
- BevZero South Africa Achieves FSSC 22000 Food Safety Certification
- Digi Communications N.V.: Digi Spain Enters Agreement to Sell FTTH Network to International Investors for Up to EUR 750 Million
- Patients as Partners® Europe Announces the Launch of 8th Annual Meeting with 2024 Keynotes and Topics
- driveMybox continues its international expansion: Hungary as a new strategic location
- Monesave introduces Socialised budgeting: Meet the app quietly revolutionising how users budget
- Digi Communications NV announces the release of the 2023 Preliminary Financial Results
- Digi Communications NV announces Investors Call for the presentation of the 2023 Preliminary Financial Results
- Lensa, един от най-ценените търговци на оптика в Румъния, пристига в България. Първият шоурум е открит в София
- Criando o futuro: desenvolvimento da AENO no mercado de consumo em Portugal
- Digi Communications N.V. Announces the release of the Financial Calendar for 2024
- Customer Data Platform Industry Attracts New Participants: CDP Institute Report
- eCarsTrade annonce Dirk Van Roost au poste de Directeur Administratif et Financier: une décision stratégique pour la croissance à venir
- BevZero Announces Strategic Partnership with TOMSA Desil to Distribute equipment for sustainability in the wine industry, as well as the development of Next-Gen Dealcoholization technology
- Digi Communications N.V. announces share transaction made by a Non-Executive Director of the Company with class B shares
- Digi Spain Telecom, the subsidiary of Digi Communications NV in Spain, has concluded a spectrum transfer agreement for the purchase of spectrum licenses
- Эксперт по торговле акциями Сергей Левин запускает онлайн-мастер-класс по торговле сырьевыми товарами и хеджированию
- Digi Communications N.V. announces the conclusion by Company’s Portuguese subsidiary of a framework agreement for spectrum usage rights
- North Texas Couple Completes Dream Purchase of Ouray’s Iconic Beaumont Hotel
- Предприниматель и филантроп Михаил Пелег подчеркнул важность саммита ООН по Целям устойчивого развития 2023 года в Нью-Йорке
- Digi Communications NV announces the release of the Q3 2023 Financial Results
- IQ Biozoom Innovates Non-Invasive Self-Testing, Empowering People to Self-Monitor with Laboratory Precision at Home
- BevZero Introduces Energy Saving Tank Insulation System to Europe under name “BevClad”
- Motorvision Group reduces localization costs using AI dubbing thanks to partnering with Dubformer
- Digi Communications NV Announces Investors Call for the Q3 2023 Financial Results
- Jifiti Granted Electronic Money Institution (EMI) License in Europe
- Предприниматель Михаил Пелег выступил в защиту образования и грамотности на мероприятии ЮНЕСКО, посвящённом Международному дню грамотности
- VRG Components Welcomes New Austrian Independent Agent
- Digi Communications N.V. announces that Digi Spain Telecom S.L.U., its subsidiary in Spain, and abrdn plc have completed the first investment within the transaction having as subject matter the financing of the roll out of a Fibre-to-the-Home (“FTTH”) network in Andalusia, Spain
- Продюсер Михаил Пелег, как сообщается, работает над новым сериалом с участием крупной голливудской актрисы
- Double digit growth in global hospitality industry for Q4 2023
- ITC Deploys Traffic Management Solution in Peachtree Corners, Launches into United States Market
- Cyviz onthult nieuwe TEMPEST dynamische controlekamer in Benelux, Nederland
- EU-Funded CommuniCity Launches its Second Open Call
- Astrologia pode dar pistas sobre a separação de Sophie Turner e Joe Jonas
- La astrología puede señalar las razones de la separación de Sophie Turner y Joe Jonas
- Empowering Europe against infectious diseases: innovative framework to tackle climate-driven health risks
- Montachem International Enters Compostable Materials Market with Seaweed Resins Company Loliware
- Digi Communications N.V. announces that its Belgian affiliated companies are moving ahead with their operations
- Digi Communications N.V. announces the exercise of conditional share options by an executive director of the Company, for the year 2022, as approved by the Company’s Ordinary General Shareholders’ Meeting from 18 May 2021
- Digi Communications N.V. announces the availability of the instruction regarding the payment of share dividend for the 2022 financial year
- Digi Communications N.V. announces the availability of the 2022 Annual Report
- Digi Communications N.V. announces the general shareholders’ meeting resolutions from 18 August 2023 approving amongst others, the 2022 Annual Accounts
- Русские эмигранты усиливают призывы «Я хочу, чтобы вы жили» через искусство
- BevZero Introduces State-of-the-Art Mobile Flash Pasteurization Unit to Enhance Non-Alcoholic Beverage Stability at South Africa Facility
- Russian Emigrés Amplify Pleas of “I Want You to Live” through Art
- Digi Communications NV announces the release of H1 2023 Financial Results
- Digi Communications NV Announces Investors Call for the H1 2023 Financial Results
- Digi Communications N.V. announces the convocation of the Company’s general shareholders meeting for 18 August 2023 for the approval of, among others, the 2022 Annual Report
- “Art Is Our Weapon”: Artists in Exile Deploy Their Talents in Support of Peace, Justice for Ukraine
- Digi Communications N.V. announces the availability of the 2022 Annual Financial Report
- “AmsEindShuttle” nuevo servicio de transporte que conecta el aeropuerto de Eindhoven y Ámsterdam
- Un nuovo servizio navetta “AmsEindShuttle” collega l’aeroporto di Eindhoven ad Amsterdam
- Digi Communications N.V. announces the conclusion of an amendment agreement to the Facility Agreement dated 26 July 2021, by the Company’s Spanish subsidiary
- Digi Communications N.V. announces an amendment of the Company’s 2023 financial calendar
- iGulu F1: Brewing Evolution Unleashed
- Почему интерактивная «Карта мира» собрала ключевые антивоенные сообщества россиян по всему миру и становится для них важнейшим инструментом
- Hajj Minister meets EU ambassadors to Saudi Arabia
- Online Organizing Platform “Map of Peace” Emerges as Key Tool for Diaspora Activists
- Digi Communications N.V. announces that conditional stock options were granted to executive directors of the Company based on the general shareholders’ meeting approval from 18 May 2021
- Digi Communications N.V. announces the release of the Q1 2023 financial results
- AMBROSIA – A MULTIPLEXED PLASMO-PHOTONIC BIOSENSING PLATFORM FOR RAPID AND INTELLIGENT SEPSIS DIAGNOSIS AT THE POINT-OF-CARE
- Digi Communications NV announces Investors Call for the Q1 2023 Financial Results presentation
- Digi Communications N.V. announces the amendment of the Company’s 2023 financial calendar
- Digi Communications N.V. announces the conclusion of two Facilities Agreements by the Company’s Romanian subsidiary
- Digi Communications N.V. announces the conclusion of a Senior Facility Agreement by the Company’s Romanian subsidiary
- Patients as Partners Europe Returns to London and Announces Agenda Highlights
- GRETE PROJECT RESULTS PRESENTED TO TEXTILE INDUSTRY STAKEHOLDERS AT INTERNATIONAL CELLULOSE FIBRES CONFERENCE
- Digi Communications N.V. announces Digi Spain Telecom S.L.U., its subsidiary in Spain, entered into an investment agreement with abrdn to finance the roll out of a Fibre-to-the-Home (FTTH) network in Andalusia, Spain
- XSpline SPA / University of Linz (Austria): the first patient has been enrolled in the international multicenter clinical study for the Cardiac Resynchronization Therapy DeliveRy guided by non-Invasive electrical and VEnous anatomy assessment (CRT-DRIVE)
- Franklin Junction Expands Host Kitchen® Network To Europe with Digital Food Hall Pioneer Casper
- Unihertz a dévoilé un nouveau smartphone distinctif, Luna, au MWC 2023 de Barcelone
- Unihertz Brachte ein Neues, Markantes Smartphone, Luna, auf dem MWC 2023 in Barcelona
- Editor's pick archive....